Azithramycine is a lipid of Polyketides (PK) class. Azithramycine is associated with abnormalities such as Respiratory Tract Infections, Pneumonia, Lower respiratory tract infection, Infection and Nonspecific urethritis. The involved functions are known as Lysis, Selection, Genetic, Mutation, Relapse and Adaptation. Azithramycine often locates in Blood, Respiratory System, Genitourinary system, Back and Chest. The associated genes with Azithramycine are Genes, rRNA, Genome, RPL22 gene, OPRM1 gene and tryptic soy broth. The related lipids are Liposomes, Phosphatidylserines, Promega, Lipopolysaccharides and Steroids. The related experimental models are Mouse Model, Knock-out and Tissue Model.
To understand associated biological information of Azithramycine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Azithramycine is suspected in Infection, Pneumonia, Trachoma, Respiratory Tract Infections, Gonorrhea, Infectious disease of lung and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Azithramycine
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Mouse Model are used in the study 'Azithromycin increases in vitro fibronectin production through interactions between macrophages and fibroblasts stimulated with Pseudomonas aeruginosa.' (Cory TJ et al., 2013), Mouse Model are used in the study 'Efficacy of azithromycin, clarithromycin and beta-lactam agents against experimentally induced bronchopneumonia caused by Haemophilus influenzae in mice.' (Miyazaki S et al., 2001), Mouse Model are used in the study 'Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor.' (Gross M et al., 2004), Mouse Model are used in the study 'Inhibition of quorum sensing in Pseudomonas aeruginosa by azithromycin and its effectiveness in urinary tract infections.' (Bala A et al., 2011) and Mouse Model are used in the study 'Enhanced efficacy of single-dose versus multi-dose azithromycin regimens in preclinical infection models.' (Girard D et al., 2005).
Knock-out are used in the study 'Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.' (Bulman ZP et al., 2017) and Knock-out are used in the study 'Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.' (Mulet X et al., 2009).
Tissue Model are used in the study 'Development of a population pharmacokinetic model characterizing the tissue distribution of azithromycin in healthy subjects.' (Zheng S et al., 2014).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Saint-Criq V et al. | Restoration of chloride efflux by azithromycin in airway epithelial cells of cystic fibrosis patients. | 2011 | Antimicrob. Agents Chemother. | pmid:21220528 |
Sato T et al. | In vitro intracellular activity and in vivo efficacy of modithromycin, a novel bicyclolide, against Legionella pneumophila. | 2011 | Antimicrob. Agents Chemother. | pmid:21220530 |
Lu Y et al. | Antibiotics Promote Escherichia coli-Pseudomonas aeruginosa Conjugation through Inhibiting Quorum Sensing. | 2017 | Antimicrob. Agents Chemother. | pmid:28993333 |
Nilius AM et al. | Comparative in vitro activity of ABT-773, a novel antibacterial ketolide. | 2001 | Antimicrob. Agents Chemother. | pmid:11408246 |
Parry CM et al. | Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever. | 2007 | Antimicrob. Agents Chemother. | pmid:17145784 |
Seral C et al. | Influence of P-glycoprotein inhibitors on accumulation of macrolides in J774 murine macrophages. | 2003 | Antimicrob. Agents Chemother. | pmid:12604540 |
Roblin PM et al. | In vitro activities of rifamycin derivatives ABI-1648 (Rifalazil, KRM-1648), ABI-1657, and ABI-1131 against Chlamydia trachomatis and recent clinical isolates of Chlamydia pneumoniae. | 2003 | Antimicrob. Agents Chemother. | pmid:12604555 |
Rodvold KA et al. | Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers. | 1997 | Antimicrob. Agents Chemother. | pmid:9174209 |
Ishida K et al. | In vitro and in vivo activities of macrolides against Mycoplasma pneumoniae. | 1994 | Antimicrob. Agents Chemother. | pmid:8031048 |
Hauser C et al. | In vitro activity of fosfomycin alone and in combination with ceftriaxone or azithromycin against clinical Neisseria gonorrhoeae isolates. | 2015 | Antimicrob. Agents Chemother. | pmid:25547354 |
Bermudez LE et al. | Stimulation with cytokines enhances penetration of azithromycin into human macrophages. | 1991 | Antimicrob. Agents Chemother. | pmid:1667256 |
Koeva M et al. | An Antipersister Strategy for Treatment of Chronic Pseudomonas aeruginosa Infections. | 2017 | Antimicrob. Agents Chemother. | pmid:28923873 |
Saiz JC and MartÃn-Acebes MA | Reply to Iannetta et al., "Azithromycin Shows Anti-Zika Virus Activity in Human Glial Cells". | 2017 | Antimicrob. Agents Chemother. | pmid:28839084 |
Riska PF et al. | Genetic and culture-based approaches for detecting macrolide resistance in Chlamydia pneumoniae. | 2004 | Antimicrob. Agents Chemother. | pmid:15328134 |
Maezono H et al. | Antibiofilm effects of azithromycin and erythromycin on Porphyromonas gingivalis. | 2011 | Antimicrob. Agents Chemother. | pmid:21911560 |
Kutlin A et al. | In vitro activities of azithromycin and ofloxacin against Chlamydia pneumoniae in a continuous-infection model. | 1999 | Antimicrob. Agents Chemother. | pmid:10471577 |
Bui KQ et al. | Mononuclear and polymorphonuclear leukocyte dispositions of clarithromycin and azithromycin in AIDS patients requiring Mycobacterium avium complex prophylaxis. | 1999 | Antimicrob. Agents Chemother. | pmid:10471584 |
Yamada K et al. | Azithromycin attenuates lung inflammation in a mouse model of ventilator-associated pneumonia by multidrug-resistant Acinetobacter baumannii. | 2013 | Antimicrob. Agents Chemother. | pmid:23733468 |
Hoffmann N et al. | Azithromycin blocks quorum sensing and alginate polymer formation and increases the sensitivity to serum and stationary-growth-phase killing of Pseudomonas aeruginosa and attenuates chronic P. aeruginosa lung infection in Cftr(-/-) mice. | 2007 | Antimicrob. Agents Chemother. | pmid:17620382 |
Bogdanovich T et al. | Activities of ceftobiprole, a novel broad-spectrum cephalosporin, against Haemophilus influenzae and Moraxella catarrhalis. | 2006 | Antimicrob. Agents Chemother. | pmid:16723565 |
Kosowska-Shick K et al. | Antipneumococcal activity of DW-224a, a new quinolone, compared to those of eight other agents. | 2006 | Antimicrob. Agents Chemother. | pmid:16723567 |
Zhanel GG et al. | Mutant prevention concentrations of levofloxacin alone and in combination with azithromycin, ceftazidime, colistin (Polymyxin E), meropenem, piperacillin-tazobactam, and tobramycin against Pseudomonas aeruginosa. | 2006 | Antimicrob. Agents Chemother. | pmid:16723591 |
Wierzbowski AK et al. | Expression of the mef(E) gene encoding the macrolide efflux pump protein increases in Streptococcus pneumoniae with increasing resistance to macrolides. | 2005 | Antimicrob. Agents Chemother. | pmid:16251306 |
Jesus FP et al. | In vitro synergism observed with azithromycin, clarithromycin, minocycline, or tigecycline in association with antifungal agents against Pythium insidiosum. | 2014 | Antimicrob. Agents Chemother. | pmid:25001300 |
Kohlhoff SA et al. | In vitro activity of a novel diaminopyrimidine compound, iclaprim, against Chlamydia trachomatis and C. pneumoniae. | 2004 | Antimicrob. Agents Chemother. | pmid:15105151 |
Hogan PA and Sheehan DJ | Macrolide susceptibility and beta-lactamase production among haemophilus influenzae isolates in the United States, 1996-1997. | 1998 | Antimicrob. Agents Chemother. | pmid:9835536 |
GarcÃa-Quintanilla M et al. | Inhibition of LpxC Increases Antibiotic Susceptibility in Acinetobacter baumannii. | 2016 | Antimicrob. Agents Chemother. | pmid:27270288 |
Kashuba AD and Amsden GW | Bronchopulmonary pharmacokinetics of clarithromycin and azithromycin. | 1998 | Antimicrob. Agents Chemother. | pmid:9527816 |
Noedl H et al. | In vitro antimalarial activity of azithromycin, artesunate, and quinine in combination and correlation with clinical outcome. | 2007 | Antimicrob. Agents Chemother. | pmid:17116669 |
Pruul H and McDonald PJ | Potentiation of antibacterial activity of azithromycin and other macrolides by normal human serum. | 1992 | Antimicrob. Agents Chemother. | pmid:1317141 |
Yeruva L et al. | Differential susceptibilities to azithromycin treatment of chlamydial infection in the gastrointestinal tract and cervix. | 2013 | Antimicrob. Agents Chemother. | pmid:24100498 |
Brown BA et al. | Activities of four macrolides, including clarithromycin, against Mycobacterium fortuitum, Mycobacterium chelonae, and M. chelonae-like organisms. | 1992 | Antimicrob. Agents Chemother. | pmid:1317144 |
Welsh LE et al. | In vitro evaluation of activities of azithromycin, erythromycin, and tetracycline against Chlamydia trachomatis and Chlamydia pneumoniae. | 1992 | Antimicrob. Agents Chemother. | pmid:1318677 |
Stamler DA et al. | Azithromycin pharmacokinetics and intracellular concentrations in Legionella pneumophila-infected and uninfected guinea pigs and their alveolar macrophages. | 1994 | Antimicrob. Agents Chemother. | pmid:8192446 |
Caronzolo D et al. | Effect of PEX, a noncatalytic metalloproteinase fragment with integrin-binding activity, on experimental Chlamydophila pneumoniae infection. | 2006 | Antimicrob. Agents Chemother. | pmid:17005805 |
Mizukane R et al. | Comparative in vitro exoenzyme-suppressing activities of azithromycin and other macrolide antibiotics against Pseudomonas aeruginosa. | 1994 | Antimicrob. Agents Chemother. | pmid:8203850 |
Heifets L et al. | Mycobacterium avium strains resistant to clarithromycin and azithromycin. | 1993 | Antimicrob. Agents Chemother. | pmid:8031351 |
Wolinsky E | Mycobacterium avium strains resistant to clarithromycin and azithromycin. | 1994 | Antimicrob. Agents Chemother. | pmid:8031406 |
Taylor WR et al. | Tolerability of azithromycin as malaria prophylaxis in adults in northeast papua, indonesia. | 2003 | Antimicrob. Agents Chemother. | pmid:12821468 |
Seral C et al. | Quantitative analysis of gentamicin, azithromycin, telithromycin, ciprofloxacin, moxifloxacin, and oritavancin (LY333328) activities against intracellular Staphylococcus aureus in mouse J774 macrophages. | 2003 | Antimicrob. Agents Chemother. | pmid:12821480 |
Taylor DE and Chang N | In vitro susceptibilities of Campylobacter jejuni and Campylobacter coli to azithromycin and erythromycin. | 1991 | Antimicrob. Agents Chemother. | pmid:1659309 |
Ressner RA et al. | Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira. | 2008 | Antimicrob. Agents Chemother. | pmid:18411316 |
Wingard JB et al. | A novel cell-associated protection assay demonstrates the ability of certain antibiotics to protect ocular surface cell lines from subsequent clinical Staphylococcus aureus challenge. | 2011 | Antimicrob. Agents Chemother. | pmid:21628536 |
Skindersoe ME et al. | Effects of antibiotics on quorum sensing in Pseudomonas aeruginosa. | 2008 | Antimicrob. Agents Chemother. | pmid:18644954 |
Jesus FP et al. | In Vitro and In Vivo Antimicrobial Activities of Minocycline in Combination with Azithromycin, Clarithromycin, or Tigecycline against Pythium insidiosum. | 2015 | Antimicrob. Agents Chemother. | pmid:26459895 |
Pankuch GA et al. | In vitro selection of resistance to four beta-lactams and azithromycin in Streptococcus pneumoniae. | 1998 | Antimicrob. Agents Chemother. | pmid:9797225 |
Bogdanovich T et al. | Effect of efflux on telithromycin and macrolide susceptibility in Haemophilus influenzae. | 2006 | Antimicrob. Agents Chemother. | pmid:16495248 |
Garey KW et al. | Lack of effect of zafirlukast on the pharmacokinetics of azithromycin, clarithromycin, and 14-hydroxyclarithromycin in healthy volunteers. | 1999 | Antimicrob. Agents Chemother. | pmid:10223928 |
Lee N et al. | Anti-inflammatory effects of adjunctive macrolide treatment in adults hospitalized with influenza: A randomized controlled trial. | 2017 | Antiviral Res. | pmid:28535933 |
Allen G | Evidence appraisal of Tita ATN, Szychowski JM, Boggess K, et al. Adjunctive azithromycin prophylaxis for cesarean delivery.: N Engl J Med. 2016;375:1231-1241. | 2017 | AORN J | pmid:28034388 |
Li Y et al. | Where macrolide resistance is prevalent. | 2015 | APMIS | pmid:25703275 |
Kärpänoja P et al. | Antimicrobial susceptibility testing of Streptococcus pneumoniae and Haemophilus influenzae --internal quality control as a quality tool on a national level. | 2013 | APMIS | pmid:23163534 |
Petrini B | Mycobacterium abscessus: an emerging rapid-growing potential pathogen. | 2006 | APMIS | pmid:16725007 |
Zavadska D et al. | Macrolide resistance in group A beta haemolytic Streptococcus isolated from outpatient children in Latvia. | 2010 | APMIS | pmid:20477812 |
Lundbäck D et al. | Molecular epidemiology of Neisseria gonorrhoeae- identification of the first presumed Swedish transmission chain of an azithromycin-resistant strain. | 2006 | APMIS | pmid:16499664 |
Drago L et al. | Kinetic bactericidal activity of telithromycin, azithromycin and clarithromycin against respiratory pathogens. | 2005 | APMIS | pmid:16309423 |
Mustapha NA et al. | Impact of different antibiotics on methane production using waste-activated sludge: mechanisms and microbial community dynamics. | 2016 | Appl. Microbiol. Biotechnol. | pmid:27531514 |
Melski JW et al. | Primary and secondary erythema migrans in central Wisconsin. | 1993 | Arch Dermatol | pmid:8389536 |
Fernandez-Obregon A | Oral use of azithromycin for the treatment of acne rosacea. | 2004 | Arch Dermatol | pmid:15096385 |
Wertman R et al. | Mycobacterium bolletii/Mycobacterium massiliense furunculosis associated with pedicure footbaths: a report of 3 cases. | 2011 | Arch Dermatol | pmid:21482895 |
McConnell K and Shields M | Azithromycin for episodes with asthma-like symptoms in young children aged 1-3 years. | 2017 | Arch Dis Child Educ Pract Ed | pmid:28735295 |
Magri V et al. | Reduction of PSA values by combination pharmacological therapy in patients with chronic prostatitis: implications for prostate cancer detection. | 2007 | Arch Ital Urol Androl | pmid:17695414 |
Magri V et al. | Eradication of unusual pathogens by combination pharmacological therapy is paralleled by improvement of signs and symptoms of chronic prostatitis syndrome. | 2007 | Arch Ital Urol Androl | pmid:17695415 |
Grand A et al. | [Subacute infectious endocarditis due to the agent of cat scratch fever: Bartonella henselae]. | 2001 | Arch Mal Coeur Vaiss | pmid:11265556 |
Guillot M et al. | [Macrolides, Pseudomonas aeruginosa and cystic fibrosis]. | 2006 | Arch Pediatr | pmid:17370396 |
Mandelcwajg A et al. | [Mediterranean spotted fever in a 3-year-old child]. | 2014 | Arch Pediatr | pmid:24630621 |
Derelle J | [Anti-inflammatory therapy in cystic fibrosis]. | 2003 | Arch Pediatr | pmid:14671937 |
Caillet-Gossot S et al. | [Clustered cases of intrafamily invasive Streptococcus pyogenes infection (or group A streptococcus)]. | 2011 | Arch Pediatr | pmid:22056211 |
Bingen E | [Antibiotic resistance of bacterial strains in paediatric infections: there are resistance and resistance!]. | 2008 | Arch Pediatr | pmid:19000854 |
Gendrel D and Cohen R | [Bacterial diarrheas and antibiotics: European recommendations]. | 2008 | Arch Pediatr | pmid:19000862 |
Floret D et al. | [Action to be taken when facing one or more cases of whooping-cough]. | 2005 | Arch Pediatr | pmid:15961299 |
Cohen R and Grimprel E | [Rational and irrational of azithromycin use]. | 2013 | Arch Pediatr | pmid:24360299 |
Amer A et al. | The natural history of pityriasis rosea in black American children: how correct is the "classic" description? | 2007 | Arch Pediatr Adolesc Med | pmid:17485628 |
Steinberg JM and Srugo I | Reoccurrence of culture-positive pertussis in an infant initially treated with azithromycin and steroids. | 2002 | Arch Pediatr Adolesc Med | pmid:12361458 |
Angelilli ML et al. | Palatability of oral antibiotics among children in an urban primary care center. | 2000 | Arch Pediatr Adolesc Med | pmid:10710025 |
McPhail GL et al. | Improving evidence-based care in cystic fibrosis through quality improvement. | 2010 | Arch Pediatr Adolesc Med | pmid:20921354 |
Casas-Maldonado F | Bronchiectasis and Azithromycin. | 2018 | Arch. Bronconeumol. | pmid:28757281 |
Méndez Abad P et al. | Idiopathic plastic bronchitis as an uncommon cause of massive pulmonary atelectasis. | 2015 | Arch. Bronconeumol. | pmid:24495947 |
Máiz Carro L | [Long-term treatment with azithromycin in a patient with idiopathic bronchiectasis]. | 2005 | Arch. Bronconeumol. | pmid:15919012 |
Espadas D et al. | Lack of effect of azithromycin on QT interval in children: a cohort study. | 2016 | Arch. Dis. Child. | pmid:27515186 |
Turner MA et al. | Azithromycin, Ureaplasma and chronic lung disease of prematurity: a case study for neonatal drug development. | 2012 | Arch. Dis. Child. | pmid:21697219 |
Srinivasan R and Yeo TH | Are newer macrolides effective in eradicating carriage of pertussis? | 2005 | Arch. Dis. Child. | pmid:15723933 |
Kirk CB | Is the frequency of recurrent chest infections, in children with chronic neurological problems, reduced by prophylactic azithromycin? | 2008 | Arch. Dis. Child. | pmid:17908711 |
Chin LK et al. | Pertussis encephalopathy in an infant. | 2013 | Arch. Dis. Child. | pmid:23251014 |
Sharma JB et al. | Comparative efficacy of two regimens in syndromic management of lower genital infections. | 2006 | Arch. Gynecol. Obstet. | pmid:16247610 |
Guven MA et al. | The demographic and behavioural profile of women with cervicitis infected with Chlamydia trachomatis, Mycoplasma hominis and Ureaplasma urealyticum and the comparison of two medical regimens. | 2005 | Arch. Gynecol. Obstet. | pmid:15778862 |
Dooley DP | Revisiting doxycycline. | 1998 | Arch. Intern. Med. | pmid:9665360 |
Feldman RB et al. | Azithromycin monotherapy for patients hospitalized with community-acquired pneumonia: a 31/2-year experience from a veterans affairs hospital. | 2003 | Arch. Intern. Med. | pmid:12885688 |
Vergis EN et al. | Azithromycin vs cefuroxime plus erythromycin for empirical treatment of community-acquired pneumonia in hospitalized patients: a prospective, randomized, multicenter trial. | 2000 | Arch. Intern. Med. | pmid:10809032 |
Malcolm C and Marrie TJ | Antibiotic therapy for ambulatory patients with community-acquired pneumonia in an emergency department setting. | 2003 | Arch. Intern. Med. | pmid:12695270 |
Silvers JA and Champney WS | Accumulation and turnover of 23S ribosomal RNA in azithromycin-inhibited ribonuclease mutant strains of Escherichia coli. | 2005 | Arch. Microbiol. | pmid:16096836 |
Lin C and Lietman T | Trachoma control: is azithromycin the answer for trichiasis too? | 2007 | Arch. Ophthalmol. | pmid:17562994 |
Woreta F et al. | Three-year outcomes of the surgery for trichiasis, antibiotics to prevent recurrence trial. | 2012 | Arch. Ophthalmol. | pmid:22159169 |
West SK et al. | Single-dose azithromycin prevents trichiasis recurrence following surgery: randomized trial in Ethiopia. | 2006 | Arch. Ophthalmol. | pmid:16534049 |
Taylor HR | Misleading titles cause confusion. | 2009 | Arch. Ophthalmol. | pmid:19204251 |
Rudich DS and Bhatnagar P | Scleritis associated with toxoplasmic retinochoroiditis. | 2012 | Arch. Ophthalmol. | pmid:22652859 |
Sommer A | Systemic antibiotics for communitywide trachoma control. | 2005 | Arch. Ophthalmol. | pmid:15883291 |
Keenan JD et al. | Cost analysis of povidone-iodine for ophthalmia neonatorum prophylaxis. | 2010 | Arch. Ophthalmol. | pmid:20065233 |
Keenan JD et al. | Slow resolution of clinically active trachoma following successful mass antibiotic treatments. | 2011 | Arch. Ophthalmol. | pmid:21482879 |
Woreta TA et al. | Effect of trichiasis surgery on visual acuity outcomes in Ethiopia. | 2009 | Arch. Ophthalmol. | pmid:19901217 |